Skip to main content

MoneyWorks4Me

Lupin informs about press release

24 Mar 2022 Evaluate
Lupin has informed that it enclosed press release titled, ‘Lupin Receives Approval from US FDA for Sildenafil for Oral Suspension’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..